Published in Circ Res on January 20, 2005
Determination of Specific Biomarkers of Angioneurotic Crisis (BIOBRAD) | NCT02833675
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol (2006) 3.95
Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal (2009) 2.17
Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol Rev (2011) 2.06
Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun (2012) 1.78
Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J (2005) 1.45
The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res (2008) 1.44
Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers. J Biol Chem (2010) 1.35
Endothelial Jagged-1 is necessary for homeostatic and regenerative hematopoiesis. Cell Rep (2013) 1.32
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med (2012) 1.31
The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol (2010) 1.28
Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules. Chem Biol Interact (2007) 1.20
Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell Tissue Res (2008) 1.16
Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin. J Virol (2008) 0.98
Similarities and differences in the regulation of leukocyte extravasation and vascular permeability. Semin Immunopathol (2014) 0.97
Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine. Am J Respir Cell Mol Biol (2011) 0.95
A critical role for Lyn kinase in strengthening endothelial integrity and barrier function. Blood (2013) 0.95
Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol Cell Biol (2007) 0.94
Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. PLoS One (2012) 0.89
Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation. Cardiovasc Diabetol (2014) 0.84
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation. Sci Rep (2016) 0.84
Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis. Oncogene (2013) 0.83
Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin. Arch Ophthalmol (2008) 0.80
Proteomic Analysis of Embryonic and Young Human Vitreous. Invest Ophthalmol Vis Sci (2015) 0.80
Novel role of reactive oxygen species-activated Trp melastatin channel-2 in mediating angiogenesis and postischemic neovascularization. Arterioscler Thromb Vasc Biol (2015) 0.80
Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: towards a candidate biomarker. PLoS One (2013) 0.79
Regulation of Endothelial Adherens Junctions by Tyrosine Phosphorylation. Mediators Inflamm (2015) 0.78
Activation of Vascular Endothelial Growth Factor (VEGF) Receptor 2 Mediates Endothelial Permeability Caused by Cyclic Stretch. J Biol Chem (2016) 0.78
Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterus. Am J Physiol Heart Circ Physiol (2014) 0.76
Blood-based biomarkers for the optimization of anti-angiogenic therapies. Cancers (Basel) (2010) 0.75
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell (1999) 7.33
Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol (1993) 5.86
Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science (1991) 4.72
Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell (1999) 4.55
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci (1998) 3.80
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol (2004) 3.47
Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol (2001) 3.30
Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol (1995) 3.06
Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol (2003) 2.92
Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J (2002) 2.74
Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med (1998) 2.64
Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br J Cancer (1984) 2.55
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest (2004) 2.48
Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol (1995) 2.25
VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc Natl Acad Sci U S A (2002) 2.08
Role of vascular endothelial-cadherin in vascular morphogenesis. Development (1999) 2.06
VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J (2002) 2.05
Cell confluence regulates tyrosine phosphorylation of adherens junction components in endothelial cells. J Cell Sci (1997) 2.01
VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci (1997) 2.00
Cell turnover of capillaries. Lab Invest (1967) 2.00
Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol (1996) 1.90
Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol (1999) 1.81
Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol (1996) 1.78
Association between a transmembrane protein tyrosine phosphatase and the cadherin-catenin complex. J Cell Biol (1996) 1.69
The nonreceptor protein tyrosine phosphatase PTP1B binds to the cytoplasmic domain of N-cadherin and regulates the cadherin-actin linkage. J Cell Biol (1998) 1.60
Vascular-endothelial-cadherin modulates endothelial monolayer permeability. J Cell Sci (1999) 1.57
SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin. J Biol Chem (2000) 1.56
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res (2002) 1.45
A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood (2002) 1.45
Dynamic interaction of PTPmu with multiple cadherins in vivo. J Cell Biol (1998) 1.42
Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest (1998) 1.40
Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol (2003) 1.39
Angiogenesis in the female reproductive system. FASEB J (1992) 1.37
Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J Biol Chem (1996) 1.33
Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol (1999) 1.32
Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells. BMC Biochem (2002) 1.23
Matrix-specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells. FASEB J (2004) 1.23
Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology (2002) 1.21
Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem (1999) 1.20
NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood (2004) 1.17
Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler Thromb Vasc Biol (2002) 1.14
Histamine stimulates phosphorylation of adherens junction proteins and alters their link to vimentin. Am J Physiol Lung Cell Mol Physiol (2002) 1.12
Alteration of endothelial cell monolayer integrity triggers resynthesis of vascular endothelium cadherin. J Biol Chem (1998) 1.12
Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules. Am J Physiol (1999) 1.07
Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest (2003) 1.06
Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology (2000) 1.06
Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability. Surgery (2002) 0.98
Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem J (2001) 0.92
Adrenocorticotrophic hormone stimulates phosphotyrosine phosphatase SHP2 in bovine adrenocortical cells: phosphorylation and activation by cAMP-dependent protein kinase. Biochem J (2000) 0.90
Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3',5'-monophosphate, and tyrosine kinase receptor pathways. Endocrinology (1995) 0.89
Structure and function of tyrosine kinase receptors. J Bioenerg Biomembr (1991) 0.88
Protein-tyrosine phosphatase-mediated decrease of epidermal growth factor and platelet-derived growth factor receptor tyrosine phosphorylation in high cell density cultures. J Biol Chem (1996) 0.87
Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells. Biochem J (1995) 0.87
Antioxidant superoxide dismutase attenuates increased endothelial permeability induced by platelet-activating factor. J Soc Gynecol Investig (2003) 0.83
Identification of membrane calcium channels essential for cytoplasmic and nuclear calcium elevations induced by vascular endothelial growth factor in human endothelial cells. Growth Factors (2001) 0.82
Tyrosine phosphatases SHP-1 and SHP-2 are associated with distinct tyrosine-phosphorylated proteins. Exp Cell Res (2002) 0.79
Intracellular stresses in patterned cell assemblies. Soft Matter (2014) 2.00
Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta (2007) 1.87
In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant. Heart Rhythm (2008) 1.61
Hereditary angioedema: key role for kallikrein and bradykinin in vascular endothelial-cadherin cleavage and edema formation. J Allergy Clin Immunol (2011) 1.45
Identification of proteases involved in the proteolysis of vascular endothelium cadherin during neutrophil transmigration. J Biol Chem (2003) 1.39
Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Res (2008) 1.26
Transient muscle paralysis disrupts bone homeostasis by rapid degradation of bone morphology. Bone (2009) 1.18
Sustained production of ROS triggers compensatory proliferation and is required for regeneration to proceed. Sci Rep (2013) 1.18
TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol Cell Biol (2007) 1.17
Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med (2006) 1.17
Photoactivation of the CreER T2 recombinase for conditional site-specific recombination with high spatiotemporal resolution. Zebrafish (2010) 1.16
A model of the guinea-pig ventricular cardiac myocyte incorporating a transverse-axial tubular system. Prog Biophys Mol Biol (2007) 1.14
The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene (2005) 1.12
The motor protein myosin-X transports VE-cadherin along filopodia to allow the formation of early endothelial cell-cell contacts. Mol Cell Biol (2010) 1.03
N-cadherin deficiency impairs pericyte recruitment, and not endothelial differentiation or sprouting, in embryonic stem cell-derived angiogenesis. Exp Cell Res (2005) 1.02
Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa. PLoS Pathog (2012) 1.00
Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys (2008) 1.00
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. FASEB J (2005) 0.99
NSP-Cas protein structures reveal a promiscuous interaction module in cell signaling. Nat Struct Mol Biol (2011) 0.97
Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat Commun (2013) 0.96
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro. J Biol Chem (2011) 0.94
Protocadherin 12 (VE-cadherin 2) is expressed in endothelial, trophoblast, and mesangial cells. Exp Cell Res (2005) 0.94
Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol Cell Biol (2007) 0.94
Synergy between extracellular modules of vascular endothelial cadherin promotes homotypic hexameric interactions. J Biol Chem (2002) 0.93
Photocontrol of protein activity in cultured cells and zebrafish with one- and two-photon illumination. Chembiochem (2010) 0.93
Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice. J Pathol (2011) 0.92
Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells. Am J Physiol Cell Physiol (2010) 0.92
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage. Arthritis Rheum (2012) 0.92
Unraveling the distinct distributions of VE- and N-cadherins in endothelial cells: a key role for p120-catenin. Exp Cell Res (2010) 0.90
Multilineage hematopoietic progenitor activity generated autonomously in the mouse yolk sac: analysis using angiogenesis-defective embryos. Int J Dev Biol (2003) 0.90
PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J Neurochem (2007) 0.89
Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol (2012) 0.89
Architecture of the VE-cadherin hexamer. J Mol Biol (2006) 0.88
C5-DNA methyltransferase inhibitors: from screening to effects on zebrafish embryo development. Chembiochem (2011) 0.88
Europe-wide survey of teaching in geriatric medicine. J Am Geriatr Soc (2008) 0.86
Cortical bone resorption following muscle paralysis is spatially heterogeneous. Bone (2011) 0.86
Implication of type 3 deiodinase induction in zebrafish fin regeneration. Gen Comp Endocrinol (2010) 0.86
The functional role of cardiac T-tubules explored in a model of rat ventricular myocytes. Philos Trans A Math Phys Eng Sci (2006) 0.85
The SH2 domain protein Shep1 regulates the in vivo signaling function of the scaffolding protein Cas. Cell Signal (2010) 0.85
Factors affecting fixation of the glenoid component of a reverse total shoulder prothesis. J Shoulder Elbow Surg (2008) 0.84
Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta. Physiol Genomics (2008) 0.84
Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Can J Cardiol (2009) 0.84
Structure of artificial and natural VE-cadherin-based adherens junctions. Biochem Soc Trans (2008) 0.84
Biomechanic analysis of trapeziectomy, ligament reconstruction with tendon interposition, and tie-in trapezium implant arthroplasty for thumb carpometacarpal arthritis: a cadaver study. J Hand Surg Am (2007) 0.84
The basic framework of VE-cadherin junctions revealed by cryo-EM. J Mol Biol (2005) 0.84
Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity. Cell Mol Life Sci (2015) 0.83
Development of a one-step embryonic stem cell-based assay for the screening of sprouting angiogenesis. BMC Biotechnol (2007) 0.83
Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH. Am J Physiol Endocrinol Metab (2003) 0.82
Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: a study of adrenocorticotropin-induced repair. Endocrinology (2003) 0.82
Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions. J Am Med Dir Assoc (2011) 0.82
Metaphyseal and diaphyseal bone loss in the tibia following transient muscle paralysis are spatiotemporally distinct resorption events. Bone (2013) 0.81
The SRC homology 2 domain protein Shep1 plays an important role in the penetration of olfactory sensory axons into the forebrain. J Neurosci (2010) 0.81
Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia. J Biol Chem (2011) 0.80
SHEP1 partners with CasL to promote marginal zone B-cell maturation. Proc Natl Acad Sci U S A (2010) 0.80
Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation. Front Pharmacol (2013) 0.80
The role of door orientation on occupant injury in a nearside impact: a CIREN, MADYMO modeling and experimental study. Traffic Inj Prev (2005) 0.80
Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol (2012) 0.78
A soluble VE-cadherin fragment forms 2D arrays of dimers upon binding to a lipid monolayer. J Mol Biol (2004) 0.77
Highly protective effects of chronic oral administration of nicorandil on the heart of ageing rats. Clin Exp Pharmacol Physiol (2002) 0.77
ACTH depletion represses vascular endothelial-cadherin transcription in mouse adrenal endothelium in vivo. J Mol Endocrinol (2005) 0.77
Developmental role of zebrafish protease-activated receptor 1 (PAR1) in the cardio-vascular system. PLoS One (2012) 0.76
Decreased circulating elastin peptide levels in humans with sepsis. Pathol Biol (Paris) (2005) 0.76
Effect of ion concentration changes in the limited extracellular spaces on sarcolemmal ion transport and Ca2+ turnover in a model of human ventricular cardiomyocyte. Int J Mol Sci (2013) 0.75
A method to assess the migration properties of cell-derived microparticles within a living tissue. Biochim Biophys Acta (2011) 0.75
BIOBRAD Study: The Search for Biomarkers of Bradykinin-Mediated Angio-Oedema Attacks. Int Arch Allergy Immunol (2016) 0.75
Soluble Vascular Endothelial Cadherin as a New Biomarker of Irradiation in Highly Irradiated Baboons with Bone Marrow Protection. Health Phys (2016) 0.75
An unusual case of cholecystitis and liver abscesses in an older adult. J Am Geriatr Soc (2012) 0.75
Differential suture loading in an experimental rotator cuff repair. Am J Sports Med (2008) 0.75
A comparison of injury criteria used in evaluating seats for whiplash protection. Traffic Inj Prev (2004) 0.75